Zota Health Care FY26 Highlights: **Business Performance:** Zota delivered stellar performance, with consolidated revenue soaring 84% YoY to ₹538.66 Cr! 🚀 Davaindia segment was the growth engine, hitting ₹417.41 Cr.

Importantly, the company turned profitable at the EBITDA level, reporting ₹25.98 Cr for FY26, a major turnaround from previous losses. **Growth & Strategy:** Davaindia's rapid expansion is key, adding a record 997 new stores in FY26, taking total count to 2,579 (COCO/FOFO). Strategic stake increase in Everyday Herbal Group to 87.78% strengthens its OTC product portfolio and supply chain.

The focus now shifts to optimizing existing stores for better profitability. **Recent Developments:** Successfully completed a ₹350 Cr QIP.

Welcomed M.S. Dhoni & Suniel Shetty as Davaindia brand ambassadors for wider reach.

Further acquired Curexis and enhanced Everyday Herbal stake. **Key Financials:** FY26 Revenue: ₹538.66 Cr (+84% YoY). FY26 EBITDA: ₹25.98 Cr.

Davaindia Gross Merchandise Value (GMV): ₹457.06 Cr. **Outlook:** Management plans to moderate Davaindia's expansion pace in the next two quarters to sharpen focus on profitability and store optimization.

The long-term vision targets 5,000+ Davaindia stores by FY29 to deliver affordable healthcare across India. 🎯